The FDA was seeking measures to provide “flexibility” to regulations in times of emergencies, according to Domingo.
FDA Director-General Eric Domingo on Thursday said that the Food and Drug Administration (FDA) was seeking the approval of measures that will allow it to have more “flexibility” in its regulations in times of emergencies.
Some lawmakers said that some of the guidelines had become “detrimental” in the fight against the pandemic.
“‘Yun nga po ang hinihiling namin kasi ang batas ng FDA para talagang walang emergency lagi kaya ang hinihiling namin sa lehislatura na talagang susuportahan namin ang bigyan ng kapangyarihan ang FDA sa panahon ng mga emergency para magkaroon tayo ng kaunting flexibility sa ating regulation,” Domingo said.
Domingo made the remark during a House hearing of the committee on good government and public accountability on the guidelines of the Department of Health (DOH) and the Food and Drug Administration (FDA) for COVID-19 drug registration, drug distribution, and drug sale sought.
READ ALSO: More Documents From Bharat Biotech Needed For Covaxin Entry In PH — DOH Official
Last December 2020, President Rodrigo Duterte allowed the Food and Drug Administration to grant an emergency use authorization (EUA) to expected COVID-19 vaccines that will be made available in the country.
President Duterte gave the Food and Drug Administration such power through Executive Order No. 121 — an executive order was issued since current FDA laws didn’t allow the agency to issue an emergency use authorization (EUA).
Bills granting the Food and Drug Administration to grant an emergency use authorization during emergency situations were still pending in the House and the Senate.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.
